Professional Documents
Culture Documents
Vaccines….
Vaccine Design
should be designed to induce the same immune responses that respond
to an actual infection and stimulate immunity to the microbial
antigens.
An Ideal Vaccine:
Should promote resistance to the disease
1. long-term cultivation,
Advantages
(1) Viable microorganisms can multiply and produce infection (but not
disease) like the natural organism;
(3) they usually require fewer doses and boosters than other types of vaccines.
Vaccines….
Disadvantages
1. they require special storage facilities,
Disadvantages
Killed vaccines do not provide as prolonged antigenic stimuli as living
vaccines and
two, three or more subcutaneous injections are required to give
adequate protection.
Vaccines….
Vaccines….
Bacterial toxoid
In some diseases such as diphtheria and tetanus, the bacterial metabolite (a
protein toxin) is the cause of the disease and not the bacteria themselves.
Toxoids are inactivated bacterial exotoxins.
Toxoids induce antibody production when injected into the body, although
they are themselves harmless.
Exposing the toxin with formaldehyde, denatures the protein.
However, some epitopes on the protein molecule are retained and they
elicit antibody production.
They require a series of injections for full immunity, followed by
boosters every 10 years.
Subunit vaccine
Subunit vaccines contain antigens or epitopes that induce protection rather
than the whole organism.
The materials usually come from the surface of the organism and hence
they are also known as surface molecule vaccines.
Several vaccines employ purified surface molecules.
The gene encoding a protein expressed on the surface of the virus, the B
surface antigen or HBsAg, can now be expressed in E. coli cells and
provides the material for an effective vaccine.
Subunit vaccine
The potential advantages of using subunits as vaccines are
the increased safety and
less antigenic competition (since only a few components are included
in the vaccine).
Disadvantages of subunit vaccines are
they generally require strong adjuvants and these adjuvants often
induce tissue reactions.
• (Adjuvants are compounds administered with vaccines so as to increase the
immunogenicity of the vaccines.)
the duration of immunity is generally shorter than with live vaccines.
Sometimes peptide epitopes may be used.
Conjugate vaccine
These are similar to subunit vaccines in the sense that only a part of the
organism is used in making the vaccine.
Some bacteria which are encapsulated cause important childhood diseases
such as septicemia, pneumonia and meningitis.
The bacteria are Hemophilus influenzae type B (HiB), Neissseria
meningitides and Streptococuus pneumoniae.
The capsules of these bacteria are made of carbohydrates which the
immune system of adults recognize as foreign, but which that of infants
do not and hence cannot make antibodies against them.
To solve the problem protein from diphtheria or tetanus toxoids is linked
or conjugated to the carbohydrate to make a vaccine.
Conjugate vaccine
This enables a baby’s immune system to respond to the combined
vaccine and produce antibodies.
The licensed conjugate vaccines against Haemophilus influenzae type
b (Hib), previously the major cause of bacterial meningitis in babies
and young children, have virtually eliminated the disease in the
United States.
Peptide vaccine
It is possible to identify the epitopes within a protein that can
induce neutralizing antibodies or epitopes that are important in T-
cell responses to vaccines.
Chemical synthesis of these epitopes is relatively straightforward.
With an appropriate adjuvant or conjugation to carrier proteins, they
can induce antibody or T-cell mediated responses to the synthesized
epitope.
These immune responses are in some cases sufficient to give
protection against the organism the protein epitope was derived from.
Advantages of this approach include
the product is stable and chemically defined without the presence
of an infectious agent and
can be designed to stimulate specific T- and B-cell responses.
are relatively simple and
require limited work-up and purification.
peptide vaccine
The major disadvantage for peptide vaccines is based on the fact that
often only one peptide is used.
Many pathogens are characterized by the fact that there is
extreme variation in the antigenic proteins of the agent.
A single epitope or even multiple epitopes are often insufficient for
protection against extreme variation of an agent such as HIV or
hepatitis C virus.
Mutants can also arise, particularly for RNA viruses, and hence
allow growth of the pathogen because the immunity generated by a
single peptide cannot recognize the mutant.
Genetic immunization
A recent development in vaccinology is immunization with
polynucleotides.
Also known as genetic immunization or DNA immunization.
Two DNA vaccines for animals have been approved; one that
protects horses from West Nile virus, and another that protects
salmon from a serious viral disease.
Advantages of polynucleotide immunization are that
it is extremely safe,
induces a broad range of immune responses (cell-mediated and
humoral responses),
long-lived immunity, and,
the animal body itself produces the vaccine which makes the
vaccine relatively inexpensive to produce.
Recombinant vaccine vectors
Genetically engineered viral or bacterial vectors that express antigens of interest.
These vectors are often employed when trying to stimulate CD8+CTL responses.
BCG
The vaccine used to immunize against tuberculosis was derived
after 13 years’ passage in bile-containing medium by Calmette and
Guerin (hence the name BCG - bacille Calmette-Guerin).
Recombinant BCG Vaccines. BCG is an avirulent bovine tubercle
bacillus that is the most widely used vaccine in the world.
Since 1948 over 5 billion vaccinations have been carried out.